Zum Hauptinhalt springen
| Hans-Günter Meyer-Thompson | Naltrexon

Slow-release naltrexone implant versus oral naltrexone for improving treatment outcomes in people with HIV who are addicted to opioids: a double-blind, placebo-controlled, randomised trial.

Slow-release naltrexone implant versus oral naltrexone for improving treatment outcomes in people with HIV who are addicted to opioids: a double-blind, placebo-controlled, randomised trial.

Krupitsky E, Blokhina E, Zvartau E, Verbitskaya E, Lioznov D, Yaroslavtseva T, Palatkin V, Vetrova M, Bushara N, Burakov A, Masalov D, Mamontova O, Langleben D, Poole S, Gross R, Woody G.

Lancet HIV. 2019 Mar 14. pii: S2352-3018(18)30362-X. doi: 10.1016/S2352-3018(18)30362-X. 

(Registrierung erforderlich)

https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30362-X/fulltext